Conference Agenda
Day 1, Friday, March 03, 2017
7:30 a.m. - 8:45 a.m.
Continental Breakfast and Registration
8:45 a.m. - 9:00 a.m.
Welcoming Remarks
• An Overview of Pharmaceutical Antitrust Litigation
Dianne M. Nast, NastLaw LLC, Philadelphia
9:00 a.m. - 9:15 a.m.
Preamble
• The Challenges Ahead, and a Primer on U.S. Pharmaceutical Expenditures, Pricing and Distribution Networks
Thomas M. Sobol, Hagens Berman Sobol Shapiro LLP, Boston
9:15 a.m. - 10:00 a.m.
Substantive Law Panel - The New Generic Conspiracies: What Violates Section One Price-Fixing Law, and What Does Not?
Linda P. Nussbaum, Nussbaum Law Group, P.C., New York
Roberta D. Liebenberg, Fine, Kaplan and Black, R.P.C., Philadelphia
Jonathan Berman, Jones Day, Washington, DC
10:00 a.m. - 10:15 a.m.
Refreshment Break
10:15 a.m. - 10:30 a.m.
Managing Law Firm Financial Risk In Pharmaceutical Antitrust Litigation Engagements
Sarah Lieber, Vice President, Underwriting and Investment, Burford Capital LLC, New York
10:30 a.m. - 11:15 a.m.
Substantive Law Panel - Post-Namenda and Doryx: What Violates Section Two Product-Hopping Law, and What Does Not?
Stephen Shadowen, Hilliard & Shadowen LLP, Austin, TX
Ellen Meriwether, Cafferty Clobes Meriwether & Sprengel LLP, Philadelphia
Jonathan Berman, Jones Day, Washington, DC
11:15 a.m. - 12:00 p.m.
Substantive Law Panel - Post-Lamictal, Loestrin and Nexium: What Violates Section One Reverse Payment Law, and What Does Not?
Peter Kohn, Faruqi & Faruqi, Philadelphia
Peter St. Phillip, Lowey Dannenberg Cohen & Hart, P.C., White Plains, NY
Christopher T. Holding, Goodwin Procter LLP, Boston
Leslie E. John, Ballard Spahr LLP, Philadelphia
Robert N. Kaplan, Kaplan Fox & Kilsheimer LLP, New York
Kristen A. Johnson, Hagens Berman Sobol Shapiro LLP, Boston
12:00 p.m. - 1:30 p.m.
Lunch - The View From the Bench
• Observations From the Bench About Lawyering Before the Courts
Hon. Gene E.K. Pratter, U.S. District Court, Eastern District of Pennsylvania, Philadelphia
Hon. Mitchell S. Goldberg, U.S. District Court, Eastern District of Pennsylvania, Philadelphia
1:30 p.m. - 2:00 p.m.
Procedural Law Panel - The Changing Tides of Ascertainability and Numerosity: Recent Wins and Losses Under Rule 23(a), Direct and Indirect
Joseph H. Meltzer, Kessler Topaz Meltzer & Check, LLP, Radnor, PA
Jeffrey L. Kodroff, Spector Roseman Kodroff & Willis, P.C., Philadelphia
Christine C. Levin, Dechert LLP, Philadelphia
Lindsay D. Breedlove, Pepper Hamilton LLP, Philadelphia
2:00 p.m. - 2:30 p.m.
Procedural Law Panel - Privilege Claim or Obstructionist Behavior: Recent Wins and Losses in the Battles to Challenge Privilege Claims and Protect Client Confidences
Sharon K. Robertson, Cohen Milstein Sellers & Toll PLLC, New York
Jayne A. Goldstein, Shepherd, Finkelman, Miller & Shah, LLP, Fort Lauderdale, FL
Jan P. Levine, Pepper Hamilton LLP, Philadelphia
2:30 p.m. - 2:45 p.m.
Refreshment Break
2:45 p.m. - 3:45 p.m.
Procedural Law Panel - Ethical Conduct of Class Actions: Conduct Towards Class Members and Opt-Outs
Arnold Levin, Levin, Sedran & Berman, Philadelphia
Christopher A. Seeger, Seeger Weiss, LLP, New York
Christine C. Levin, Dechert LLP, Philadelphia
Mark S. Cheffo, Quinn Emanuel, Urquhart & Sullivan LLP, New York
3:45 p.m. - 4:30 p.m.
Putting It All Together
• Anatomy of a Trial
• An Autopsy of the Nexium Trial and Appeal
• How is Antitrust Injury and Damages Proven, or Disproven, in a Private Reverse Payment Case?
Thomas M. Sobol, Hagens Berman Sobol Shapiro LLP, Boston
Laurence A. Schoen, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Boston